The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction
EuroIntervention 2012;8:71-78 publish online ahead of print February 2012. DOI: 10.4244/EIJV8I1A12
Pascal Vranckx1, MD; Gianluca Campo2, MD; Maurizio Anselmi3, MD; Leonardo Bolognese4, MD; Salvatore Colangelo5, MD; Giuseppe Biondi-Zoccai6, MD; Raul Moreno7, MD; Tommaso Piva8, MD; Luca Favero9, MD; Francesco Prati10, MD, PhD; Marco Nazzaro11, MD, PhD; José F. Díaz Fernández12, MD; Roberto Ferrari2, MD, PhD; Marco Valgimigli2*, MD, PhD; for the Multicenter Evaluation of Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Investigators
1. Hartcentrum, Hasselt, Belgium; 2. University of Ferrara, Ferrara, Italy and Cardiovascular Research Center, Salvatore Maugeri Foundation, IRCCS, Gussago (BS), Italy; 3. Department of Biomedical and Surgical Sciences, Cardiology Secti
Aims: While bleeding in patients with STEMI undergoing primary percutaneous coronary intervention (pPCI) is known to be associated with poor out